Arca Biopharma | ABIO - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Amgen USD 1.58B 354M 2026-03
Arca Biopharma USD 2.23M 1.08M 2025-12
Biogen USD 554.3M 128.2M 2026-03
Brainstorm Cell Therapeutics USD 1.39M 326K 2025-12
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Capricor Therapeutics USD 1.92M 446.47K 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.21M 120K 2025-12
CSL USD 1.23B 498M 2025-12
Cytokinetics USD 104.9M 13.17M 2026-03
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.12B 558M 2026-03
Grifols EUR 320.45M 12.65M 2025-12
Laboratory Of America USD 551M 12.4M 2026-03
Myriad Genetics USD 122.3M 6.7M 2025-12
Otsuka Holdings JPY 259.49B 18.81B 2026-03
Pfizer USD 2.92B 1.16B 2026-03
United Therapeutics USD 190.6M 38.6M 2025-12